New research reveals that hematoma derived growth factor (HDGF) may be a good biomarker to predict disease severity in pulmonary arterial hypertension (PAH) patients.
A number of patients with advanced lung cancer may live longer if treated surgically but few elect to do it, according to a study.
Novartis announced positive data from the FLAME study evaluating the efficacy of the once-daily Ultibro Breezhaler for reducing COPD exacerbations.
A new pilot project at St. Paul's Hospital in Canada will follow COPD patients after their release from the hospital to teach them better disease management.
The adoption of a multiplex respiratory virus testing platform did not significantly reduce antibiotic prescriptions among those with other noninfluenza respiratory pathogens.
According to a study, younger COPD patents and those who are socioeconomically disadvantaged are less likely to quit smoking than older, more affluent patients.
A new paper indicates that there is no proof of the added benefit of using umeclidinium bromide for symptom relief in COPD patients.
A new study indicates that there is little awareness of the chemical components of cigarette smoke among US adults despite having looked for relevant information.
Microorganisms that cause CAP show seasonal variation, with incidence usually rising during wintertime.
The results from an ongoing Phase 3 study supports the long-term use of riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH).
Researchers found that the number of individuals with COPD who received PR increased from 2.6% in 2003 to 3.7% in 2012.
Electronic cigarette makers and sellers are making all kinds of health claims, many of which likely won't stand up to scrutiny under recently announced FDA regulation, a new study has found.
Data from 2013 through 2016 found that FluMist offered children aged 2 to 17 virtually no protection against the flu.
Patient stratification to deliver personalized medicine may be of great help in understanding and managing pulmonary diseases, such as idiopathic pulmonary fibrosis.
Users can place the device, called FitSleep, under their pillow or mattress in order to track various aspects of their sleeping pattern.
The American Academy of Sleep Medicine (AASM) has released official recommendations for the amount of sleep needed to promote optimal health in children and teens.
The drug candidate, Mul-1867, has shown promise in treating the mixed bacterial and fungal infections found in cystic fibrosis (CF) patients, according to new data.
Adherium's Smartinhaler platform will be used in a new US clinical study that aims to improve medication adherence in patients with COPD by AstraZeneca.
Sleep apnea may increase the risk of serious complications in people who have undergone angioplasty to clear blocked heart arteries, according to research.
A new experimental antibiotic successfully treats MRSA infection and restores the efficacy of a commonly prescribed antibiotic that has become ineffective against MRSA, reports Science Daily.